Why Do GLP-1 Receptor Agonists Show Different Pharmacological Profiles Despite Targeting the Same Receptor?
Type 2 diabetes, obesity, and related metabolic diseases all involve abnormalities in glucose homeostasis, pancreatic endocrine function, food intake, and energy balance. GLP-1R can simultaneously regulate insulin secretion, glucagon, gastric emptying, and feeding behavior and has therefore ...
危险品化学品经营许可证(带存储)